ENL
ENL
ENL - Enaleni Pharmaceuticals Limited - Revised trading update
Enaleni Pharmaceuticals Limited
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(JSE code: ENL & ISIN: ZAE000067740)
("Enaleni")
Revised trading update
Shareholders are referred to the trading update released earlier today, and
are advised that the headline earnings per share will be 170% to 180%
higher than those of the prior comparative period, and not 110% to 120% as
previously reported. Earnings per share will be 110% to 120% higher than
those of the prior comparative period, as reported.
27 February 2007
Sponsor
Nedbank Capital
Date: 27/02/2007 17:24:44 Produced by the JSE SENS Department.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
